EXPAREL: Revolutionizing Post-Surgical Pain Relief
Pacira BioSciences introduces EXPAREL, an opioid-sparing pain management solution. Promising Phase 3 study outcomes show significant pain reduction and decreased ...
- Latest
- Trending
Pacira BioSciences introduces EXPAREL, an opioid-sparing pain management solution. Promising Phase 3 study outcomes show significant pain reduction and decreased ...
Lexaria Bioscience announces a $3.6 million offering and private placement to enhance operational capabilities and drive innovation in the pharmaceutical ...
Ethereum and Solana are showing high potential breakouts, with Ethereum aiming for a resistance level at $2,850 and Solana challenging ...
MannKind completes enrollment for the INHALE-1 study, evaluating the efficacy of inhaled insulin Afrezza for pediatric diabetes treatment. Positive trial ...
Comcast faces challenges in its broadband segment and overall market growth, leading to a downgrade. However, potential growth drivers and ...
Morgan Stanley downgrades US Steel to 'Equalweight' from 'Overweight' and raises price target to $51. Strategic review and Nippon Steel's ...
KangaMoon's entry into the meme coin arena gains momentum, catching the attention of Ethereum and Solana holders. This showcases the ...
Bitcoin's price surge to $52k triggers massive short squeeze, wiping out over $180m worth of short positions. It also pushes ...
Yellow Pages Limited reports mixed Q4 results amid market challenges, but demonstrates resilience with strong earnings and strategic initiatives for ...
Ethereum's price rally continues as it surpasses $2,800, fueled by factors like DeFi activity, Ethereum 2.0 anticipation, institutional adoption, NFT ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.